|
2025
|
Invention
|
Antibodies to amyloid beta.
Antibody for human amyloid beta. Antibody selectively binds human am... |
|
|
Invention
|
Polypeptides and uses thereof.
Disclosed are polypeptides which are pramlintide analogues and us... |
|
|
Invention
|
Compounds.
Binding members, e.g. human antibody molecules, which bind interleukin-6 (IL-6) and n... |
|
|
Invention
|
Combination therapies using anti-pseudomonas psl and pcrv binding molecules.
This disclosure rel... |
|
|
Invention
|
Antibodies to alpha-synuclein and uses thereof.
The invention provides antibodies that specifica... |
|
2024
|
Invention
|
Methods for treating hepcidin-mediated disorders.
Methods for treating hepcidin-mediated disorde... |
|
|
Invention
|
Method for bioprotac design. The present disclosure provides methods for identifying bioPROTACs c... |
|
|
Invention
|
Method of treatment of asthma. The present disclosure relates to a method of treatment of a subje... |
|
|
Invention
|
Heterodimeric relaxin fusions and uses thereof.
The present invention relates to heterodimeric R... |
|
|
Invention
|
Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of ... |
|
|
Invention
|
Rsv-specific antibodies and functional parts thereof.
This application provides antibodies and f... |
|
|
Invention
|
Binding molecules. An antigen binding protein, such as an antibody or antigen-binding fragment th... |
|
|
Invention
|
Therapeutic binding molecules.
The invention relates to binding molecules, such as antibodies, t... |
|
|
Invention
|
Formulations of monoclonal antibodies.
The present invention provides a formulation comprising: ... |
|
|
Invention
|
Dosage regimens for and compositions including anti-rsv antibodies.
In one aspect, this disclosu... |
|
|
Invention
|
B7-h4 therapeutic binding molecules for the treatment of cancer. The disclosure relates to method... |
|
|
Invention
|
Antibodies to amyloid beta. Antibody for human amyloid beta. Antibody selectively binds human amy... |
|
|
Invention
|
Combination therapy comprising anti-cd22 antibody-drug conjugate and irak1 inhibitor. This disclo... |
|
|
Invention
|
Pyrrolobenzodiazepine-antibody conjugates and uses thereof.
The present disclosure relates to no... |
|
|
Invention
|
Migraine therapy. The disclosure generally provides compositions and methods that are useful in t... |
|
|
Invention
|
Compounds and methods for treating pain.
This disclosure provides compositions and methods for c... |
|
2023
|
Invention
|
Combination therapy for treatment of cancer comprising anti-pd-l1 and anti-cd73 antibodies. The d... |
|
|
Invention
|
Compositions and methods for neoadjuvant treatment in cancer comprising anti-cd39 antibodies. The... |
|
|
Invention
|
Antibody molecule for human gm-csf receptor alpha.
Binding members for alpha chain of receptor f... |
|
|
Invention
|
Anti-b7-h1 antibodies for treating tumors.
Provided herein are methods of treating B7-H1-express... |
|
|
Invention
|
Therapeutic binding molecules.
The present invention relates to binding molecules (e.g. antibodi... |
|
|
Invention
|
Treatment of asthma with an anti-interleukin-33 antibody. The present disclosure relates to metho... |
|
|
Invention
|
Method of selecting patients for treatment with an il-33 axis antagonist. The present disclosure ... |
|
|
Invention
|
Treatment of acute respiratory failure. The present disclosure provides a method of treating or p... |
|
|
Invention
|
Assay for detection of il-33. The present disclosure relates to a method for detecting antigenica... |
|
|
Invention
|
Antibodies to ticagrelor and methods of use. The disclosure generally provides antibodies and ant... |
|
|
Invention
|
Il33 antibodies and methods of using the same.
The present invention provides isolated IL-33 pro... |
|
|
Invention
|
Heterodimeric relaxin fusions and uses thereof. The present invention relates to heterodimeric Re... |
|
|
Invention
|
Pyrrolobenzodiazepines and conjugates thereof. A compound which is either A:
and salts and solv... |
|
|
Invention
|
Methods for reducing respiratory infections.
The disclosure relates to methods for reducing infe... |
|
|
Invention
|
Combination therapy with an anti-axl antibody-pbd conjugate and nanocups.
This disclosure relate... |
|
|
Invention
|
Dosage regimen.
This disclosure relates to dosage regimens for the treatment of proliferative di... |
|
2022
|
Invention
|
Treatment using heterodimeric relaxin fusions.
The present invention relates to uses of heterodi... |
|
|
Invention
|
Immunotherapy for cancer.
An antibody-drug conjugate (ADC) comprising an anti-human SEMA4A human... |
|
|
Invention
|
Treatment of chronic obstructive pulmonary disease with an anti-interleukin-33 antibody.
The pre... |
|
|
Invention
|
Methods for treating atopic dermatitis and related disorders.
The present invention relates to m... |
|
|
Invention
|
Methods for treating vascular inflammation, atherosclerosis and related disorders.
The present i... |
|
|
Invention
|
An anti-tslp fab with improved stability.
The present disclosure relates to an anti-TSLP Fab wit... |
|
2021
|
Invention
|
Hydrogen peroxide evolved host cell.
A directed evolution method for improving performance of a ... |
|
|
Invention
|
Compounds and methods for treating pain.
The disclosure provides novel methods and dosage regime... |
|
|
Invention
|
A scoring method for an anti-b7h4 antibody-drug conjugate therapy.
The present invention relates... |
|
2020
|
Invention
|
Fusion proteins comprising an e2 ubiquitin or ubiquitin-like conjugating domain and a targeting d... |
|
2003
|
G/S
|
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and ... |
